Autolus Therapeutics (AUTL) News Today $3.08 +0.07 (+2.33%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period 298,086 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Acquired by GSA Capital Partners LLPGSA Capital Partners LLP bought a new position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 298,086 shares of the company's stock, valued at approximately $1,082,000November 16 at 4:48 AM | marketbeat.comRedburn Atlantic Upgrades Autolus Therapeutics plc - Depositary Receipt () (AUTL)November 16 at 1:48 AM | msn.comAutolus Therapeutics upgraded to Buy from Neutral at Redburn AtlanticNovember 15 at 8:46 PM | markets.businessinsider.comAutolus Therapeutics plc (NASDAQ:AUTL) Short Interest UpdateAutolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 7,190,000 shares, a decrease of 17.8% from the October 15th total of 8,750,000 shares. Based on an average trading volume of 1,120,000 shares, the short-interest ratio is currently 6.4 days.November 15 at 8:43 PM | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Trading Up 4% - Still a Buy?Autolus Therapeutics (NASDAQ:AUTL) Trading 4% Higher - Should You Buy?November 15 at 2:50 PM | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Upgraded to Buy at Redburn AtlanticRedburn Atlantic upgraded shares of Autolus Therapeutics from a "neutral" rating to a "buy" rating and set a $13.00 target price on the stock in a report on Friday.November 15 at 8:30 AM | marketbeat.comEquities Analysts Set Expectations for AUTL FY2024 EarningsAutolus Therapeutics plc (NASDAQ:AUTL - Free Report) - Research analysts at William Blair cut their FY2024 EPS estimates for shares of Autolus Therapeutics in a note issued to investors on Tuesday, November 12th. William Blair analyst M. Phipps now forecasts that the company will post earnings ofNovember 15 at 7:35 AM | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Earns "Buy" Rating from Needham & Company LLCNovember 15 at 2:59 AM | americanbankingnews.comAutolus Therapeutics Q3 2024 Financial Update and FDA ApprovalNovember 13, 2024 | markets.businessinsider.comAutolus Therapeutics plc (NASDAQ:AUTL) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comAutolus Therapeutics PLC (AUTL) Q3 2024 Earnings Call Highlights: Strategic Advances and ...November 13, 2024 | finance.yahoo.comAutolus Therapeutics Reports Third Quarter 2024 Financial Results and Business UpdatesNovember 13, 2024 | finance.yahoo.comAutolus Therapeutics Wins FDA Approval for AUCATZYL®November 13, 2024 | markets.businessinsider.comAutolus Therapeutics plc 2024 Q3 - Results - Earnings Call PresentationNovember 12, 2024 | seekingalpha.comWhat To Expect From Autolus Therapeutics PLC (AUTL) Q3 2024 EarningsNovember 11, 2024 | finance.yahoo.comAutolus Therapeutics' (AUTL) "Buy" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $9.00 price objective on shares of Autolus Therapeutics in a report on Monday.November 11, 2024 | marketbeat.comAutolus Therapeutics Gets FDA Approval for Cancer TreatmentNovember 9, 2024 | marketwatch.comPositive Outlook for Autolus Therapeutics Amid Upcoming PDUFA Review and CAR-T AdvancementsNovember 9, 2024 | markets.businessinsider.comAutolus wins FDA approval of Aucatzyl for acute lymphoblastic leukemiaNovember 9, 2024 | msn.comAutolus Therapeutics announces FDA approval of AucatzylNovember 9, 2024 | markets.businessinsider.comAutolus Therapeutics (NASDAQ:AUTL) Trading Down 10.1% - Time to Sell?Autolus Therapeutics (NASDAQ:AUTL) Shares Down 10.1% - Here's What HappenedNovember 8, 2024 | marketbeat.comAutolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)November 8, 2024 | globenewswire.comAutolus Therapeutics to present clinical data updates at ASH 2024November 6, 2024 | markets.businessinsider.comAutolus Therapeutics (AUTL) to Release Earnings on TuesdayAutolus Therapeutics (NASDAQ:AUTL) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641167)November 5, 2024 | marketbeat.comFurther weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71%November 3, 2024 | finance.yahoo.comAutolus Therapeutics (NASDAQ:AUTL) Shares Down 4.6% - What's Next?Autolus Therapeutics (NASDAQ:AUTL) Trading Down 4.6% - Time to Sell?October 30, 2024 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Sees Large Drop in Short InterestAutolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 8,750,000 shares, a drop of 13.3% from the September 30th total of 10,090,000 shares. Based on an average trading volume of 801,900 shares, the days-to-cover ratio is presently 10.9 days.October 29, 2024 | marketbeat.comAutolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024October 28, 2024 | globenewswire.comSG Americas Securities LLC Sells 121,911 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)SG Americas Securities LLC decreased its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 64.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 67,329 shares of the company's stock after selling 121,911October 22, 2024 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Down 5% - Should You Sell?Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 5% - Here's WhyOctober 21, 2024 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - What's Next?Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Should You Buy?October 18, 2024 | marketbeat.comAutolus Therapeutics (AUTL): High-Growth UK Stock in Cancer TherapyOctober 18, 2024 | msn.comAutolus Therapeutics (NASDAQ:AUTL) Sees Large Volume Increase - Here's WhyAutolus Therapeutics (NASDAQ:AUTL) Sees Unusually-High Trading Volume - Here's WhyOctober 17, 2024 | marketbeat.comAutolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma CongressOctober 16, 2024 | markets.businessinsider.comWhy Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to AnalystsOctober 16, 2024 | msn.comAutolus Therapeutics plc (NASDAQ:AUTL) Shares Acquired by Millennium Management LLCMillennium Management LLC boosted its stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 113.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 813,031 shares of the company's stock after acquiring an additional 432,503 shares during theOctober 15, 2024 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Up 5.4% - What's Next?Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 5.4% - What's Next?October 11, 2024 | marketbeat.comPerpetual Ltd Cuts Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL)Perpetual Ltd trimmed its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 33.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,599,252 shares of the company's stock after selling 801,160 shares during the quartOctober 11, 2024 | marketbeat.comAutolus Therapeutics PLC (AUTL) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...October 9, 2024 | finance.yahoo.comMarshall Wace LLP Has $2.64 Million Stock Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)Marshall Wace LLP lowered its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 27.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 757,535 shares of the company's stock after selling 282,142October 4, 2024 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comTruist Financial Remains a Buy on Autolus Therapeutics (AUTL)October 4, 2024 | markets.businessinsider.comAutolus Therapeutics (NASDAQ:AUTL) Trading Up 8.3%Autolus Therapeutics (NASDAQ:AUTL) Shares Up 8.3%October 2, 2024 | marketbeat.comRenaissance Technologies LLC Raises Stock Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)Renaissance Technologies LLC lifted its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 253.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,145,056 shares of the comSeptember 29, 2024 | marketbeat.comFred Alger Management LLC Cuts Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL)Fred Alger Management LLC lessened its holdings in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 99.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,262 shares of the company's stock after selliSeptember 28, 2024 | marketbeat.comAutolus Therapeutics (AUTL) Gets a Buy from Truist FinancialSeptember 27, 2024 | markets.businessinsider.comArmistice Capital LLC Has $21.75 Million Stake in Autolus Therapeutics plc (NASDAQ:AUTL)Armistice Capital LLC increased its position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 33.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,250,000 shares of the coSeptember 26, 2024 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Shares Bought by Affinity Asset Advisors LLCAffinity Asset Advisors LLC increased its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 27.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,300,000 shares of the company'September 25, 2024 | marketbeat.comGreat Point Partners LLC Has $11.98 Million Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)Great Point Partners LLC grew its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 195.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,441,667 shares of the coSeptember 24, 2024 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Down 4.8% Autolus Therapeutics (NASDAQ:AUTL) Trading Down 4.8%September 23, 2024 | marketbeat.com Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back… Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov AUTL Media Mentions By Week AUTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUTL News Sentiment▼0.340.55▲Average Medical News Sentiment AUTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUTL Articles This Week▼234▲AUTL Articles Average Week Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ImmunityBio News Today Apellis Pharmaceuticals News Today Merus News Today Bausch Health Companies News Today Edgewise Therapeutics News Today Xenon Pharmaceuticals News Today PTC Therapeutics News Today Agios Pharmaceuticals News Today MoonLake Immunotherapeutics News Today Kymera Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUTL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
